Targeting I2PP2A by FTY720: A novel, mechanism-based treatment strategy for patients with advanced and previously treated non-small cell lung cancer (NSCLC).
G. R. Simon
No relevant relationships to disclose
S. Saddoughi
No relevant relationships to disclose
A. Mukhopadhyay
No relevant relationships to disclose
Y. Peterson
No relevant relationships to disclose
C. E. Senkal
No relevant relationships to disclose
J. Oaks
No relevant relationships to disclose
D. Perrotti
No relevant relationships to disclose
Y. Hannun
No relevant relationships to disclose
B. Ogretmen
No relevant relationships to disclose